Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05805150 · ClinicalTrials.gov registry record · NA

Performance Evaluation of Daily Disposable Contact Lenses in Habitual Lens Wearers Who Use Digital Devices Frequently

A NA study of Myopia, sponsored by CooperVision.

Completed
Registry status
NA
Development phase
69
Enrollment target
4
Study locations

NCT05805150 is a NA study of Myopia that has completed, run by CooperVision. The registered enrollment target is 69 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (74% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05805150, a NA study of Myopia, has completed, sponsored by CooperVision.

COMPLETED
Registry status
NA
Development phase
69 participants
Enrollment target
4
Study locations

Study Summary

The goal of this study is to compare the performance of two daily disposable silicone hydrogel lenses.

Conditions Studied

Interventions

  • DEVICE Control Lens (stenfilcon A)
  • DEVICE Test Lens (senofilcon A)

Study Locations (4)

Kansas

  • Kannarr Eye Care - Pittsburg

Minnesota

  • Complete Eye Care of Medina - Medina

Pennsylvania

  • Nittany Eye Associates - State College

Rhode Island

  • West Bay Eye Associates - Warwick

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2023-03-13
Est. Completion 2023-06-01
Phase NA

Sponsor

CooperVision

64 total trials

What the Registry Record Tells You About NCT05805150

The ClinicalTrials.gov registry entry for NCT05805150 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (74% lower). The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Control Lens (stenfilcon A) is the first listed.

NCT05805150 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Kansas, Minnesota, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05805150 about?

NCT05805150 is a clinical study titled "Performance Evaluation of Daily Disposable Contact Lenses in Habitual Lens Wearers Who Use Digital Devices Frequently". The goal of this study is to compare the performance of two daily disposable silicone hydrogel lenses.

What is the current status of trial NCT05805150?

This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2023-03-13. Estimated completion is 2023-06-01.

What conditions does trial NCT05805150 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT05805150?

The interventions under investigation include: Control Lens (stenfilcon A) (DEVICE), Test Lens (senofilcon A) (DEVICE).

Who is sponsoring clinical trial NCT05805150?

This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05805150 being conducted?

This trial has 4 study locations across Kansas, Minnesota, Pennsylvania, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.